Sera Prognostics Company Insiders

SERA Stock  USD 2.76  0.08  2.82%   
Sera Prognostics employs about 63 people. The company is managed by 13 executives with a total tenure of roughly 147 years, averaging almost 11.0 years of service per executive, having 4.85 employees per reported executive. Analysis of Sera Prognostics' management performance can provide insight into the company performance.
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sera Prognostics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For information on how to trade Sera Stock refer to our How to Trade Sera Stock guide.

Sera Prognostics Management Team Effectiveness

The company has return on total asset (ROA) of (0.221) % which means that it has lost $0.221 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.4136) %, meaning that it created substantial loss on money invested by shareholders. Sera Prognostics' management efficiency ratios could be used to measure how well Sera Prognostics manages its routine affairs as well as how well it operates its assets and liabilities.

Sera Prognostics Workforce Comparison

Sera Prognostics is rated below average in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 2,002. Sera Prognostics holds roughly 63.0 in number of employees claiming about 3% of equities under Health Care industry.

Sera Prognostics Insider Trading

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Sera Prognostics insiders, such as employees or executives, is commonly permitted as long as it does not rely on Sera Prognostics' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Sera Prognostics insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Sera Prognostics Notable Stakeholders

A Sera Prognostics stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Sera Prognostics often face trade-offs trying to please all of them. Sera Prognostics' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Sera Prognostics' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Evguenia MBACEO PresidentProfile
MS MDExecutive DirectorProfile
Benjamin JDGeneral CounselProfile
Steven GravesCoFounder BoardProfile
Lee AndersonChief OfficerProfile
John BonifaceChief OfficerProfile
Paul KearneyChief OfficerProfile
Robert HarrisonChief OfficerProfile
Austin AertsChief OfficerProfile
Sean MDCoFounder BoardProfile
MBA MBAChief OfficerProfile
Michael MDChief OfficerProfile
Nadia AltomareChief OfficerProfile

About Sera Prognostics Management Performance

The success or failure of an entity such as Sera Prognostics often depends on how effective the management is. Sera Prognostics management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Sera management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Sera management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Sera Prognostics, Inc., a womens health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company was incorporated in 2008 and is headquartered in Salt Lake City, Utah. Sera Prognostics operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 113 people.
Please note, the presentation of Sera Prognostics' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Sera Prognostics' management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Sera Prognostics' management manipulating its earnings.

Sera Prognostics Workforce Analysis

Traditionally, organizations such as Sera Prognostics use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Sera Prognostics within its industry.

Sera Prognostics Manpower Efficiency

Return on Sera Prognostics Manpower

Revenue Per Employee1.2K
Revenue Per Executive5.9K
Net Loss Per Employee522.2K
Net Loss Per Executive2.5M
Working Capital Per Employee362.4K
Working Capital Per Executive1.8M

Complementary Tools for Sera Stock analysis

When running Sera Prognostics' price analysis, check to measure Sera Prognostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sera Prognostics is operating at the current time. Most of Sera Prognostics' value examination focuses on studying past and present price action to predict the probability of Sera Prognostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sera Prognostics' price. Additionally, you may evaluate how the addition of Sera Prognostics to your portfolios can decrease your overall portfolio volatility.
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Bonds Directory
Find actively traded corporate debentures issued by US companies